Addus Homecare Co. (ADUS) Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. cut its position in Addus Homecare Co. (NASDAQ:ADUS) by 82.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,400 shares of the company’s stock after selling 21,000 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Addus Homecare were worth $299,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Legal & General Group Plc raised its stake in Addus Homecare by 32.5% during the 3rd quarter. Legal & General Group Plc now owns 1,428 shares of the company’s stock valued at $100,000 after acquiring an additional 350 shares during the last quarter. Smith Asset Management Group LP raised its stake in Addus Homecare by 3.6% during the 3rd quarter. Smith Asset Management Group LP now owns 26,034 shares of the company’s stock valued at $1,826,000 after acquiring an additional 900 shares during the last quarter. Martingale Asset Management L P raised its stake in Addus Homecare by 3.9% during the 3rd quarter. Martingale Asset Management L P now owns 32,103 shares of the company’s stock valued at $2,253,000 after acquiring an additional 1,200 shares during the last quarter. Teachers Advisors LLC raised its stake in Addus Homecare by 8.2% during the 3rd quarter. Teachers Advisors LLC now owns 17,138 shares of the company’s stock valued at $1,202,000 after acquiring an additional 1,306 shares during the last quarter. Finally, American International Group Inc. raised its stake in Addus Homecare by 26.3% during the 3rd quarter. American International Group Inc. now owns 6,277 shares of the company’s stock valued at $440,000 after acquiring an additional 1,309 shares during the last quarter. 94.98% of the stock is owned by hedge funds and other institutional investors.

Several analysts have commented on the company. Zacks Investment Research downgraded Addus Homecare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 5th. Robert W. Baird raised Addus Homecare from a “neutral” rating to an “outperform” rating and upped their price objective for the company from $72.00 to $75.00 in a research note on Monday, February 4th. BidaskClub downgraded Addus Homecare from a “buy” rating to a “hold” rating in a research note on Friday, January 11th. Finally, Oppenheimer increased their target price on Addus Homecare from $72.00 to $80.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 7th. Two equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. Addus Homecare currently has an average rating of “Buy” and a consensus target price of $76.63.

In other news, insider W Bradley Bickham sold 705 shares of the stock in a transaction that occurred on Thursday, January 17th. The stock was sold at an average price of $64.13, for a total transaction of $45,211.65. Following the completion of the transaction, the insider now directly owns 21,010 shares of the company’s stock, valued at approximately $1,347,371.30. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO R Dirk Allison sold 1,080 shares of the stock in a transaction that occurred on Tuesday, January 22nd. The stock was sold at an average price of $63.00, for a total value of $68,040.00. Following the transaction, the chief executive officer now directly owns 40,995 shares of the company’s stock, valued at $2,582,685. The disclosure for this sale can be found here. Over the last three months, insiders have sold 925,185 shares of company stock valued at $67,049,102. Company insiders own 34.80% of the company’s stock.

Shares of ADUS stock opened at $65.97 on Wednesday. The company has a market cap of $851.63 million, a PE ratio of 45.50, a price-to-earnings-growth ratio of 1.94 and a beta of -0.12. Addus Homecare Co. has a 12-month low of $33.25 and a 12-month high of $77.82. The company has a quick ratio of 4.19, a current ratio of 4.19 and a debt-to-equity ratio of 0.37.

ILLEGAL ACTIVITY NOTICE: “Addus Homecare Co. (ADUS) Shares Sold by Oppenheimer & Co. Inc.” was originally reported by Markets Daily and is owned by of Markets Daily. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.themarketsdaily.com/2019/02/13/addus-homecare-co-adus-shares-sold-by-oppenheimer-co-inc.html.

About Addus Homecare

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.

Further Reading: What is a stock split?

Institutional Ownership by Quarter for Addus Homecare (NASDAQ:ADUS)

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply